Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia M Lee

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Discovery|May 16, 2012
Another LAP in the raceSylvia M Lee, Cassian Yee
Translational Lung Cancer Research|March 26, 2015
A new addition to the PD-1 checkpoint inhibitors for non-small cell lung cancer-the anti-PDL1 antibody-MEDI4736Sylvia M Lee, Laura Q Chow
Current Treatment Options in Oncology|March 16, 2019
Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell CarcinomaHannan A Qureshi, Sylvia M Lee
Oncology (Williston Park, N.Y.)|February 17, 2015
Systemic therapy of metastatic melanoma: on the road to cureShailender Bhatia, Scott S Tykodi, Sylvia M Lee, et al.
Cancer Immunology Research|May 3, 2019
Endogenous CD4<sup>+</sup> T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <i>KRAS</i> and <i>ERBB2</i> (<i>Her2</i>) Driver MutationsJoshua R Veatch, Brenda L Jesernig, Julia Kargl, et al.
Oral Oncology|February 26, 2022
Impact of HPV status on immune responses in head and neck squamous cell carcinomaHannan A Qureshi, Xiaodong Zhu, Grace H Yang, et al.
Cancer|September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933Sylvia M Lee, James Moon, Bruce G Redman, et al.
Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.
Nature Communications|February 2, 2017
Neutrophils dominate the immune cell composition in non-small cell lung cancerJulia Kargl, Stephanie E Busch, Grace H Y Yang, et al.
The Journal of Clinical Investigation|January 24, 2018
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanomaJoshua R Veatch, Sylvia M Lee, Matthew Fitzgibbon, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Discovery|May 16, 2012
Another LAP in the raceSylvia M Lee, Cassian Yee
Translational Lung Cancer Research|March 26, 2015
A new addition to the PD-1 checkpoint inhibitors for non-small cell lung cancer-the anti-PDL1 antibody-MEDI4736Sylvia M Lee, Laura Q Chow
Current Treatment Options in Oncology|March 16, 2019
Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell CarcinomaHannan A Qureshi, Sylvia M Lee
Oncology (Williston Park, N.Y.)|February 17, 2015
Systemic therapy of metastatic melanoma: on the road to cureShailender Bhatia, Scott S Tykodi, Sylvia M Lee, et al.
Cancer Immunology Research|May 3, 2019
Endogenous CD4<sup>+</sup> T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <i>KRAS</i> and <i>ERBB2</i> (<i>Her2</i>) Driver MutationsJoshua R Veatch, Brenda L Jesernig, Julia Kargl, et al.
Oral Oncology|February 26, 2022
Impact of HPV status on immune responses in head and neck squamous cell carcinomaHannan A Qureshi, Xiaodong Zhu, Grace H Yang, et al.
Cancer|September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933Sylvia M Lee, James Moon, Bruce G Redman, et al.
Future Oncology (London, England)|January 5, 2021
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentaryArthur Sillah, Scott S Tykodi, Evan T Hall, et al.
Nature Communications|February 2, 2017
Neutrophils dominate the immune cell composition in non-small cell lung cancerJulia Kargl, Stephanie E Busch, Grace H Y Yang, et al.
The Journal of Clinical Investigation|January 24, 2018
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanomaJoshua R Veatch, Sylvia M Lee, Matthew Fitzgibbon, et al.
Pageof 3